CAN:s bibliotek

*000      ab a        ar
*00114995
*008070120s1996||||sw|||||e||||||||||||swe||            
*24510$aConsensus conference on the neuropharmacology of alcohol dependence and the role of pharmacotherapy in its treatment :$bAmsterdam, The Netherlands, September 16-17 1994
*260  $aOxford :$bPergamon,$ccop. 1996
*300  $a87 s :$bill.
*520  $aReview of neurotransmitters and their role in alcoholism treatment. The role of neurotransmitters in alcohol dependence: animal research. Alcohol reinforcement and neuropharmacological therapeutics. Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: an overview of the preclinical data. Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions. The pharmacological treatment of alcohol dependence: needs and possibilities. New "state" markers for the detection of alcoholism. Subtypes of alcoholism and their role in therapy. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism. Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse. Voice of the victims - the key to consensus and support for alcoholism research. (From the table of contents)
*650 4$aAlcoholism
*650 4$aGenetics
*650 4$aBrain chemistry
*650 4$aDrug therapy
*650 4$aAnimal
*650 4$aNaltrexone
*650 4$aNarcotic antagonists
*650 4$aNeurochemistry
*650 4$aNeuropharmacology
*653  $aAlkoholism
*653  $aGenetik
*653  $aHjärnan
*653  $aLäkemedel
*653  $aDjurförsök
*653  $aNeurokemi
*653  $aFarmakologi
*7111 $aConference on the neuropharmacology of alcohol dependence and the role of pharmacotherapy in its treatment$c(Amsterdam, The Netherlands :$d1994)
*7730 $tAlcohol and alcoholism$x0735-0414$g31(1996):suppl. 1
^